Patients are celebrating trials for newly targetable genetic diseases like Huntington's. But enrollment criteria means not all can benefit.
Andrew JosephClinical trials have to have limits. But when a drug for an untreatable disease is being tested, the demand is overwhelming.
On a Huntington's disease trial, and patients who could or couldn't enroll, with multimedia from @Matthew_Orr@DomnicSmithy